Washington University Career Development Program in Drug Abuse and Addiction

华盛顿大学药物滥用和成瘾职业发展计划

基本信息

  • 批准号:
    10460704
  • 负责人:
  • 金额:
    $ 47.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-05-01 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

Abstract Substance use disorder is multifactorial with genetic and environmental contributions and this illness is a leading cause of death worldwide. Approaches from single disciplines have done much to advance science, and methodological and technological advances have established the need for increasingly multidisciplinary approaches to address complex questions about substance use disorder. Bringing this potential of scientific discovery to advance the prevention and treatment of substance use disorder requires clinician scientists who can bridge the gaps between scientific discovery and clinical care. The goal of the K12 program is to train the next generation of clinician scientists to fill these gaps and undertake this important and exciting work. To accomplish this goal, we have established three aims: 1. Expand the workforce of clinician scientists in the prevention and treatment of substance use disorder. We will fund two scholar faculty positions per year at Washington University School of Medicine. Using a scholar-centric approach, we will design a career development plan that will meet each scholar’s needs and interests. We will provide short-term and long-term mentorship through formal mentoring relationships with local and national faculty and advisors from multiple disciplines. New opportunities to aid the scholars include wellness and resilience support, career coaching, and guidance for work/life balance. We are committed to the training and retention of scholars from diverse backgrounds. 2. Continue to develop and enhance the K12 career development opportunities and continue robust evaluation and tracking of K12 scholars, faculty, mentors, curriculum, and training opportunities. We will enhance our current program by implementing online individual career development plans that can be monitored by scholars, mentors, and Program Directors. A Research Navigator will increase support of the scholars in managing and conducting their research projects. We will monitor and evaluate the scholars, mentors, faculty and training programs using surveys, interviews, and other metrics. 3. Establish a national network of NIDA K12 Program Directors and scholars. This national consortium will serve as an avenue of communication between Program Directors and scholars across all NIDA K12 programs, creating a community with common goals, with the intent to share resources, enhance networking, and foster the development of the next generation of researchers in substance use disorder. Successful completion of these aims will result in increased numbers of diverse, well-trained clinician scientists in the prevention and treatment of substance use disorder and its consequences.
摘要 物质使用障碍是多因素的遗传和环境的贡献,这种疾病是一个 是世界范围内的主要死因来自单一学科的方法对推动科学进步有很大作用, 方法和技术的进步已经建立了越来越多的多学科的需要, 解决有关物质使用障碍的复杂问题的方法。将科学的潜力 推进物质使用障碍的预防和治疗的发现需要临床科学家, 可以弥合科学发现和临床护理之间的差距。K12计划的目标是培养 下一代临床科学家填补这些空白,并承担这项重要而令人兴奋的工作。到 为了实现这一目标,我们确立了三个目标: 1.扩大预防和治疗药物使用的临床科学家队伍 disorder.我们将每年资助华盛顿大学医学院的两名学者教师职位。 我们将采用以学生为中心的方法,设计一个职业发展计划, 需要和利益。我们将通过正式的指导提供短期和长期的指导 与来自多个学科的当地和国家教师和顾问的关系。新的援助机会 奖学金包括健康和复原力支持、职业辅导和工作/生活平衡指导。 我们致力于培养和留住来自不同背景的学者。 2.继续发展和加强K12职业发展机会,并继续保持强劲 评估和跟踪K12学者,教师,导师,课程和培训机会。 我们将通过实施在线个人职业发展计划来加强我们目前的计划, 由学者、导师和项目主管监督。研究导航员将增加对 学者在管理和开展他们的研究项目。我们会监察及评估 使用调查、访谈和其他指标的学者、导师、教师和培训计划。 3.建立NIDA K12项目主任和学者的全国网络。这个全国性的财团 将作为所有NIDA K12项目总监和学者之间的沟通渠道 计划,创建一个具有共同目标的社区,旨在共享资源, 网络,并促进下一代物质使用障碍研究人员的发展。 这些目标的成功完成将导致多样化,训练有素的临床科学家数量的增加 预防和治疗药物使用障碍及其后果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura J. Bierut其他文献

Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices
肺癌个性化治疗和戒烟的基因组学见解:激励高危个体采取基于证据的健康实践
  • DOI:
    10.1016/j.ebiom.2024.105441
  • 发表时间:
    2024-12-01
  • 期刊:
  • 影响因子:
    10.800
  • 作者:
    Tony Chen;Giang Pham;Louis Fox;Nina Adler;Xiaoyu Wang;Jingning Zhang;Jinyoung Byun;Younghun Han;Gretchen R.B. Saunders;Dajiang Liu;Michael J. Bray;Alex T. Ramsey;James McKay;Laura J. Bierut;Christopher I. Amos;Rayjean J. Hung;Xihong Lin;Haoyu Zhang;Li-Shiun Chen
  • 通讯作者:
    Li-Shiun Chen
Exposure to and Content of Marijuana Product Reviews
  • DOI:
    10.1007/s11121-017-0818-9
  • 发表时间:
    2017-07-05
  • 期刊:
  • 影响因子:
    2.700
  • 作者:
    Patricia A. Cavazos-Rehg;Melissa J. Krauss;Shaina J. Sowles;Gabrielle M. Murphy;Laura J. Bierut
  • 通讯作者:
    Laura J. Bierut
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis
  • DOI:
    10.1186/s13722-024-00530-1
  • 发表时间:
    2025-01-06
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Kevin Y. Xu;Jennifer K. Bello;Joanna Buss;Hendrée E. Jones;Laura J. Bierut;Dustin Stwalley;Hannah S. Szlyk;Caitlin E. Martin;Jeannie C. Kelly;Ebony B. Carter;Elizabeth E. Krans;Richard A. Grucza
  • 通讯作者:
    Richard A. Grucza
Genetik der Nikotinabhängigkeit
尼古丁的遗传学
  • DOI:
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sarah M. Hartz;Laura J. Bierut
  • 通讯作者:
    Laura J. Bierut
Correction: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis
  • DOI:
    10.1186/s13722-025-00556-z
  • 发表时间:
    2025-03-11
  • 期刊:
  • 影响因子:
    3.200
  • 作者:
    Kevin Y. Xu;Jennifer K. Bello;Joanna Buss;Hendrée E. Jones;Laura J. Bierut;Dustin Stwalley;Hannah S. Szlyk;Caitlin E. Martin;Jeannie C. Kelly;Ebony B. Carter;Elizabeth E. Krans;Richard A. Grucza
  • 通讯作者:
    Richard A. Grucza

Laura J. Bierut的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura J. Bierut', 18)}}的其他基金

Linking Direct to Consumer Genomics and Electronic Health Records to Accelerate Science
直接连接消费者基因组学和电子健康记录以加速科学发展
  • 批准号:
    10195133
  • 财政年份:
    2021
  • 资助金额:
    $ 47.68万
  • 项目类别:
Multi 'Omics Integration and Neurobiological Signatures of Alcohol Use Disorder
酒精使用障碍的多组学整合和神经生物学特征
  • 批准号:
    10461091
  • 财政年份:
    2019
  • 资助金额:
    $ 47.68万
  • 项目类别:
Multi 'Omics Integration and Neurobiological Signatures of Alcohol Use Disorder
酒精使用障碍的多组学整合和神经生物学特征
  • 批准号:
    10023922
  • 财政年份:
    2019
  • 资助金额:
    $ 47.68万
  • 项目类别:
Multi 'Omics Integration and Neurobiological Signatures of Alcohol Use Disorder
酒精使用障碍的多组学整合和神经生物学特征
  • 批准号:
    10678775
  • 财政年份:
    2019
  • 资助金额:
    $ 47.68万
  • 项目类别:
Washington University Career Development Program in Drug Abuse and Addiction
华盛顿大学药物滥用和成瘾职业发展计划
  • 批准号:
    9917745
  • 财政年份:
    2017
  • 资助金额:
    $ 47.68万
  • 项目类别:
Washington University Career Development Program in Drug Abuse and Addiction
华盛顿大学药物滥用和成瘾职业发展计划
  • 批准号:
    10657611
  • 财政年份:
    2017
  • 资助金额:
    $ 47.68万
  • 项目类别:
Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare Variants
戒烟对尼古丁的依赖:对常见和罕见变异进行测序
  • 批准号:
    8839761
  • 财政年份:
    2014
  • 资助金额:
    $ 47.68万
  • 项目类别:
Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare Variants
戒烟对尼古丁的依赖:对常见和罕见变异进行测序
  • 批准号:
    9271304
  • 财政年份:
    2014
  • 资助金额:
    $ 47.68万
  • 项目类别:
Nicotine Dependence to Smoking Cessation: Sequencing Common and Rare Variants
戒烟对尼古丁的依赖:对常见和罕见变异进行测序
  • 批准号:
    8722284
  • 财政年份:
    2014
  • 资助金额:
    $ 47.68万
  • 项目类别:
Data Management
数据管理
  • 批准号:
    8137973
  • 财政年份:
    2010
  • 资助金额:
    $ 47.68万
  • 项目类别:

相似海外基金

Evaluating the use of verbal autopsy methods for producing cause of death estimates in Uganda
评估乌干达使用口头尸检方法进行死因估计的情况
  • 批准号:
    2587582
  • 财政年份:
    2021
  • 资助金额:
    $ 47.68万
  • 项目类别:
    Studentship
Improving Communication of Cause of Death and Heritable Heart Disease Risk to Families of Sudden Cardiac Death Victims: A Mixed Methods Study
改善对心脏性猝死受害者家属的死因和遗传性心脏病风险的沟通:一项混合方法研究
  • 批准号:
    437956
  • 财政年份:
    2020
  • 资助金额:
    $ 47.68万
  • 项目类别:
    Operating Grants
Establishing and evaluating minimally invasive autopsy to determine cause of death from infectious disease in Vietnam
建立和评估微创尸检以确定越南传染病死因
  • 批准号:
    MR/R026300/1
  • 财政年份:
    2020
  • 资助金额:
    $ 47.68万
  • 项目类别:
    Research Grant
A research on victim considering cause of death in Miyagi Prefecture in the Great East Japan Earthquake
东日本大地震宫城县受害者死因研究
  • 批准号:
    20K14999
  • 财政年份:
    2020
  • 资助金额:
    $ 47.68万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Population attributable risk estimation for major cause of death associated with family history in Japanese
日本与家族史相关的主要死亡原因的人群归因风险估计
  • 批准号:
    19K24186
  • 财政年份:
    2020
  • 资助金额:
    $ 47.68万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Erroneous Coding of Developmental Disabilities as Underlying Cause of Death
将发育障碍错误编码为潜在死因
  • 批准号:
    10078585
  • 财政年份:
    2020
  • 资助金额:
    $ 47.68万
  • 项目类别:
Identification of genes that influence methamphetamine toxicity and application to cause of death investigation
影响甲基苯丙胺毒性的基因鉴定及其在死因调查中的应用
  • 批准号:
    19K10698
  • 财政年份:
    2019
  • 资助金额:
    $ 47.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Bayesian analysis of cause of death assignment using verbal autopsy data
使用口头尸检数据进行死因分配的贝叶斯分析
  • 批准号:
    18K12756
  • 财政年份:
    2018
  • 资助金额:
    $ 47.68万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Symptom normalization for cause of death prediction using machine learning
使用机器学习进行症状标准化以预测死因
  • 批准号:
    526962-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 47.68万
  • 项目类别:
    University Undergraduate Student Research Awards
Development of a method to investigate cause of death related to fatty acid oxidation disorder.
开发一种调查与脂肪酸氧化障碍相关的死亡原因的方法。
  • 批准号:
    18K10118
  • 财政年份:
    2018
  • 资助金额:
    $ 47.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了